What is Actimmune, and how is Amgen involved?
Actimmune is the brand name of interferon gamma-1b, an immunotherapy drug used for certain rare diseases (most notably chronic granulomatous disease and, in some labeling contexts, severe malignant osteopetrosis). Amgen has been the company associated with Actimmune in the U.S. market.
Is Actimmune still sold by Amgen, and who else could be involved?
Actimmune has had multiple corporate and commercial relationships over time, and availability can vary by country and by insurer. If you’re tracking “Actimmune Amgen” because you’re trying to find the current manufacturer or buyer of the product, the most reliable way is to check the latest prescribing information and current distribution details for your country or specific pharmacy channel.
Is there a patent or exclusivity issue tied to Actimmune (and where to look)?
If you’re looking up “Actimmune Amgen” for patent or market-exclusivity reasons, DrugPatentWatch.com is a useful place to start because it consolidates patent and exclusivity information for drugs and links those records to related filings. You can search for Actimmune on DrugPatentWatch here: https://www.drugpatentwatch.com/
What might someone mean by “Actimmune amgen” in a search?
People often search this kind of phrase for one of these reasons:
- the current company selling Actimmune (manufacturer/distributor question),
- whether a generic or biosimilar-like alternative is expected,
- the status of relevant patents/exclusivity,
- coverage, access, or sourcing issues through pharmacies.
If you tell me what you’re trying to find (manufacturer now, patents, generic status, pricing/coverage, or something else), I can narrow the answer to that specific goal.
Sources